Skip to main content

Modern Slavery Act Statement

Modern Slavery act statement 

Probiotics International Ltd (Protexin) Modern Slavery Act Statement for the financial year 2016/2017

This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 (MSA 2015) and sets out the steps Probiotics International Ltd (Protexin) has taken to ensure that modern slavery and human trafficking is not taking place in any part of the company’s supply chains or own business.

Modern slavery is a crime results in abhorrent abuse of human rights. The term “modern slavery” is used to encapsulate the crimes of slavery, servitude, forced or compulsory labour and human trafficking.

Company Structure

Probiotics International Ltd (Protexin), founded in 1992, is a UK registered company with registered company number 01122942. Probiotics International Ltd (Protexin) has a subsidiary company, Protexin Inc, based in the US (EIN 36-4835605)

Probiotics International Ltd (Protexin) manufactures and distributes Probiotic and nutraceutical supplements for people and animals in the UK and to approximately 90 countries worldwide. Protexin Inc is a wholly owned subsidiary of Probiotics International Ltd promoting and distributing products into the North American market.

Probiotics International Ltd (Protexin) employs 135 personnel, the majority of which are based at the office, manufacturing and warehouse facilities in Somerset, UK.  Remaining personnel are home based across the UK.  Protexin Inc currently employs 4 personnel who are based at the Florida office and warehouse facilities.

The company’s management structure is available on request.

Relevant policies

The Modern Slavery Policy and Whistleblowing Policy are available to all staff (not currently in handbook).The handbook is available to all staff members who are each required to read and sign that they have read and understood the content on commencing employment or when updates or additions are included. Staff induction also includes Modern Slavery awareness.

Where temporary workers are employed, Probiotics International Ltd works with an accredited Stronger Together Business Partner, who has successfully implemented a ‘Tackling Modern Slavery’ policy.

Due diligence process

Probiotics International Ltd is committed to reducing modern slavery and human trafficking within its supply chain of raw materials and other appropriate suppliers of goods and services. To this end, PIL includes desktop auditing in its process of supplier approval to include questions directly related to the MSA in order to ascertain supplier level of compliance and understanding of the MSA 2015. The returned forms are assessed and approved or otherwise with relevant action or further investigations as required. A copy of the questionnaire is available on request.

Identifying areas of risk to PILs supply chain

Probiotics International Ltd has a range of suppliers of raw materials, packaging, other componentry and services that are themselves accredited to appropriate industry standards. On a risk-based approach, Probiotics International Ltd considers current suppliers to be low risk using the “Stronger 2gether” risk screening resource.

Effectiveness of PILs Approach to Reducing Slavery and Human Trafficking in its Supply Chain?

This will be informed by the responses to the MSA relevant supplier questionnaire and any resulting action required to be taken.

Training

All staff at PIL have been made aware if the Company’s response to the MSA 2015 and or questions asked of suppliers. Senior staff members and those working most closely with suppliers of raw materials, packaging, other componentry and services have received or attended more detailed in-house or external training using Government resources, such as Stronger 2 together resources, intended for such a purpose.

Statement approval

This statement is made in accordance with the Modern Slavery Act 2015 section 54(1) and constitutes the Probiotics International Ltd Slavery and Human Trafficking Statement for the financial year ending 31Jul2017.

The Directors of PIL delegated approval of this statement on its behalf to the Managing Director of Probiotics International Ltd .

 

 

                          

Date: 14th June 2017

Toby Lewis

Managing Director

 

CP-0026 Rev0